Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E-coli nitroreductase gene

被引:0
|
作者
Searle, PF
Weedon, SJ
McNeish, I
Gilligan, MG
Ford, MJ
Friedlos, F
Springer, CJ
Young, LS
Kerr, DJ
机构
[1] UNIV BIRMINGHAM,CRC,INST CANC STUDIES,BIRMINGHAM B15 2TA,W MIDLANDS,ENGLAND
[2] GLAXO WELLCOME RES & DEV LTD,STEVENAGE SG1 2NY,HERTS,ENGLAND
[3] INST CANC RES,SUTTON SM2 5NG,SURREY,ENGLAND
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:304 / 304
页数:1
相关论文
共 37 条
  • [1] Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E-coli nitroreductase gene
    Searle, PF
    Weedon, SJ
    McNeish, IA
    Gilligan, MG
    Ford, MJ
    Friedlos, F
    Springer, CJ
    Young, LS
    Kerr, DJ
    GENE THERAPY OF CANCER, 1998, 451 : 107 - 113
  • [2] Gene therapy for pancreatic cancer: In vivo killing of tumour cells expressing E-coli nitroreductase following administration of the prodrug CB1954
    Green, NK
    Youngs, DJ
    Young, LS
    Kerr, DJ
    Neoptolemos, JP
    Searle, PF
    GUT, 1997, 41 : A188 - A188
  • [3] Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E-coli nitroreductase
    Weedon, SJ
    Green, NK
    McNeish, IA
    Gilligan, MG
    Mautner, V
    Wrighton, CJ
    Mountain, A
    Young, LS
    Kerr, DJ
    Searle, PF
    INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (06) : 848 - 854
  • [4] Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E-coli nitroreductase and CB1954
    McNeish, IA
    Green, NK
    Gilligan, MG
    Ford, MJ
    Mautner, V
    Young, LS
    Kerr, DJ
    Searle, PF
    GENE THERAPY, 1998, 5 (08) : 1061 - 1069
  • [5] Virus-directed enzyme prodrug therapy using retrovirally delivered E-coli nitroreductase and CB1954
    McNeish, IA
    Gilligan, MG
    Green, NK
    Roberts, SM
    Kerr, DJ
    Friedlos, F
    Springer, CJ
    Searle, PF
    BRITISH JOURNAL OF CANCER, 1998, 78 (02) : 155 - 156
  • [6] Gene therapy for cancer:: In vivo killing of tumour cells expressing E-coli nitroreductase following administration of the prodrug CD1954.
    Green, NK
    Weedon, SJ
    McNeish, IA
    Mautner, V
    Young, LS
    Kerr, DJ
    Searle, PF
    GENE THERAPY, 1999, 6 : S9 - S9
  • [7] E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
    Vass, S. O.
    Jarrom, D.
    Wilson, W. R.
    Hyde, E. I.
    Searle, P. F.
    BRITISH JOURNAL OF CANCER, 2009, 100 (12) : 1903 - 1911
  • [8] E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
    S O Vass
    D Jarrom
    W R Wilson
    E I Hyde
    P F Searle
    British Journal of Cancer, 2009, 100 : 1903 - 1911
  • [9] Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954
    IA McNeish
    NK Green
    MG Gilligan
    MJ Ford
    V Mautner
    LS Young
    DJ Kerr
    PF Searle
    Gene Therapy, 1998, 5 : 1061 - 1069
  • [10] Towards gene therapy in prosthesis loosening: efficient killing of interface cells by gene-directed enzyme prodrug therapy with nitroreductase and the prodrug CB1954
    de Poorter, JJ
    Toboom, TCA
    Rabelink, MJWE
    Pieterman, E
    Hoeben, RC
    Nelissen, RGHH
    Huizinga, TWJ
    JOURNAL OF GENE MEDICINE, 2005, 7 (11): : 1421 - 1428